India to begin trials for Ayurvedic drugs to fight COVID-19
The AYUSH Ministry is working to validate four Ayurvedic medicine formulations against COVID-19 along with Council of Scientific and Industrial Research (CSIR). The trials will begin within a week. These formulations will be tried as an add-on therapy and standard care for COVID-19 patients.
Union Minister of State for AYUSH Shripad Y Naik revealed this matter on Twitter. He hoped Ayurveda would show positive results to overcome this pandemic.
CSIR Director-General Shekhar Mande and AYUSH secretary Vaidya Rajesh Kotecha said that result will come within three months once the clinical trials begin.
CSIR Director-General Shekhar Mande said that Ayurveda principles existed long before and it is vital to validate at least some of them. It is the right time to validate Ayurvedic formulations to fight against coronavirus pandemic.
The AYUSH secretary said that four Ayurvedic formulations, Ashwagandha, Yashtimadhu (Mulethi), Guduchi and Pippali (Giloy) are going to be tested against COVID-19.
He added that repurposing of the malarial drug, AYUSH-64 will be done. He added that two stimulus studies are planned on the high-risk population for Ashwagandha. A competitive study has been planned between Hydroxychloroquine and Ashwagandha.
This clinical study will be conducted in various parts of the country with variable design. A task force has been formed to prepare guidelines for a clinical trial.
Many scientists across the country from the medical field from CSIR and other institutions have reviewed it. The advice of ICMR has also been taken in this regard.
They identified the centres and investigators and finalized all things for the clinical trial. AYUSH also approved to start the trial.
Standard drugs have been procured as per the standard size requirements. They are planning to begin the trials in the next week.
Image Credit: Image by Pradeep Kumar from Pixabay (Free for commercial use)
You may also like
Image Reference: https://pixabay.com/photos/ayurvedic-herbal-alternative-756352/
Recent Posts
- Ivory raises $500K to combat Dementia among India’s elderlyDementia, a looming health crisis, affects one individual every 20 seconds in India, particularly those over 55.
- WhatsApp eyes global expansion with international UPI paymentsAlthough WhatsApp has yet to make an official announcement, the leaked information suggests the feature is in development,
- CHIAL announces vacancy for Company Secretary positionTo kickstart the application process, eligible candidates should visit the official ICSI website.
- Ivory raises $500K to combat Dementia among India’s elderly
What’s new at WeRIndia.com
News from 700+ sources
-
Smart TV prices to go up this year, shipments down 16 pc in India in 2023: Report
-
Kriti Sanon reveals she dreamt of debuting opposite Salman, also expresses her desire to work with Vidya Balan
-
Biden administration restores threatened species protections dropped by Trump
-
‘DMK wants power at Centre, State so they can loot easily’: AIADMK’s Palaniswami at Tamil Nadu’s Madurai
-
New Salernitana coach hoping good things come in threes
-
Fetch.ai hits new ATH: Time to buy FET or are you too late now?
-
WeRIndia – A News Aggregator
Visit werindia.com for all types of National | Business | World | Politics | Entertainment | Health related news and much more..
Leave a Reply